Gujarat Themis Biosyn Share Price
Small Cap | Pharmaceuticals and health care | NSE: GUJTHEM | BSE: 506879
₹262.45 -19.75 (-7.00 %)
Last Updated: 04 Apr 2025 03:43 PM
Overview
Open (₹) 284.45
High (₹) 284.45
Low (₹) 260.50
Prev. Close (₹) 282.20
Volume 80,958
VWAP (₹) 224.33
ROCE (%) 38.82
Industry P/E 44.73
TTM P/E 54.34
P/B Ratio 9.47
Market Cap (₹) Cr.2,859.79
Dividend Yield (%)0.38
EPS (₹) 8.14
ROE29.37%
Sales Growth (%) 14.00
Profit Growth (%)2.06
Day Range
284.45284.45
52 Week Range
192.35390.00
Historical Returns
Returns (6M)
7.8 %
Returns (1Y)
7.8 %
Returns (3Y)
7.8 %
Returns (5Y)
7.8 %
Returns (6M)
7.8 %
Returns (1Y)
7.8 %
Returns (3Y)
7.8 %
Returns (5Y)
7.8 %
SWOT Analysis
Technicals
Technical Rating
RSI N/A
MFI N/A
ATR N/A
Commodity Channel Index N/A
ROC125 N/A
ROC21 N/A
Williams %R N/A
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 234.29 | 249.66 | 260.34 | 223.61 | 208.24 | 197.56 | 182.19 |
EMA & SMA
262.45
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
0
5 Day N/A
9 Day N/A
10 Day N/A
12 Day N/A
14 Day N/A
20 Day N/A
26 Day N/A
50 Day N/A
100 Day N/A
200 Day N/A
Deals & Announcements
Bulk and Block Deals
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
29 Dec, 2023 | Pharmaceutical Business Group [India] Ltd | Disposal | ₹215.13 | 30,00,000 | NSE |
28 Sept, 2023 | Mrs.Avantika Vijay Agarwal | Acquisition | ₹913.86 | 5,400 | NSE |
18 Dec, 2021 | Mrs.Avantika Vijay Agarwal | Disposal | ₹500.71 | 3,704 | NSE |
15 Dec, 2021 | Ms. Avantika Vijay Agarwal | Disposal | ₹501.49 | 656 | NSE |
15 Dec, 2021 | Ms. Avantika Vijay Agarwal | Disposal | ₹503.97 | 9,032 | NSE |
20 Sept, 2021 | Pharmaceutical Business Group India Limited | Acquisition | ₹150.00 | 38,50,000 | NSE |
20 Sept, 2021 | Yuhan Corporation | Disposal | ₹150.00 | 38,50,000 | NSE |
17 Jun, 2021 | Mr.Rajneesh Anand | Acquisition | ₹295.21 | 5,250 | NSE |
17 Jun, 2021 | Mr.Rajneesh Anand | Acquisition | ₹286.51 | 1,750 | NSE |
12 Mar, 2021 | Ms. Indu Vijay Agarwal | Disposal | ₹214.73 | 5,000 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
14 May, 2024 | Bonus issue in the ratio of 1:2 of Re. 1/-. | 09 Aug, 2024 | 09 Aug, 2024 |
14 May, 2024 | Rs.0.2500 per share(25%)Final Dividend | 15 Jul, 2024 | 01 Jan, 1970 |
12 Feb, 2024 | Rs.0.7500 per share(75%)Interim Dividend | 22 Feb, 2024 | 22 Feb, 2024 |
15 May, 2023 | Rs.1.0000 per share(20%)Final Dividend | 01 Sept, 2023 | 01 Jan, 1970 |
13 May, 2023 | Stock split from Rs. 5/- to Re. 1/-. | 10 Oct, 2023 | 10 Oct, 2023 |
Announcements
Date | Source | Detail |
---|---|---|
25 Mar, 2025 | NSE India | Gujarat Themis Biosyn Limited has informed the Exchange about Closure of Trading Window |
25 Mar, 2025 | NSE India | Gujarat Themis Biosyn Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
21 Feb, 2025 | BSE India | Please refer to the attachment. |
14 Feb, 2025 | BSE India | Please refer to the attachment. |
14 Feb, 2025 | BSE India | Please refer to the attached Investor presentation for detailed information. |
14 Feb, 2025 | BSE India | Please refer to the attachment. |
14 Feb, 2025 | BSE India | Please refer to the attachment. |
14 Feb, 2025 | BSE India | Please refer to the attachment. |
02 Jan, 2025 | BSE India | Please refer to the attachment. |
18 Nov, 2024 | BSE India | Please refer attached annexure for further information |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 11 Feb, 2025 | 14 Feb, 2025 |
Quarterly Results | -- | 22 Oct, 2024 | 25 Oct, 2024 |
Quarterly Results | -- | 18 Jul, 2024 | 26 Jul, 2024 |
Audited Results, Dividend & Bonus issue | -- | 07 May, 2024 | 14 May, 2024 |
Quarterly Results & Interim Dividend | -- | 08 Feb, 2024 | 10 Feb, 2024 |
Quarterly Results | -- | 26 Oct, 2023 | 04 Nov, 2023 |
Quarterly Results | -- | 03 Aug, 2023 | 12 Aug, 2023 |
Quarterly Results | -- | 07 Aug, 2023 | 10 Aug, 2023 |
Audited Results, F. Dividend & Stock Split | -- | 05 May, 2023 | 13 May, 2023 |
Quarterly Results | -- | 30 Jan, 2023 | 03 Feb, 2023 |
Share Holding Pattern
Owner Name | Feb, 2025 | Sept, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
---|---|---|---|---|---|
Promoter Group | 70.86% | 70.86% | 70.86% | 74.99% | 74.99% |
Foreign Institutions + | 1.47% | 1.49% | 0.86% | 0.01% | 0% |
Domestic Institutions + | 1.17% | 1.17% | 0.04% | 0.03% | 0.31% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 26.5% | 26.48% | 28.24% | 24.97% | 24.7% |
Others | 0% | 0% | 0% | 0% | 0% |
About Gujarat Themis Biosyn
Gujarat Themis Biosyn is a Public Limited Listed company incorporated on 11/12/1981 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1981PLC004878 and registration number is 004878. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 169.82 Cr. and Equity Capital is Rs. 7.26 Cr. for the Year ended 31/03/2024.
Parent Organisation
Joint Sector Holding
Founded
1981
Managing Director
-- --
NSE Symbol
--
Gujarat Themis Biosyn Management
Name | Designation |
---|---|
Dr. Dinesh S Patel | Chairman & Non-Exe.Director |
Dr. Sachin D Patel | Promoter Non-Exe.Director |
Mr. Vijay Agarwal | Ind. Non-Executive Director |
Dr. Vikram D Sanghvi | Ind. Non-Executive Director |
Mr. Siddharth Y Kusumgar | Ind. Non-Executive Director |
Mrs. Kirandeep Kaur Madan | Ind. Non-Executive Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Gujarat Themis Biosyn
What is the share price of Gujarat Themis Biosyn?
The share price of Gujarat Themis Biosyn on 04 Apr, 2025 is ₹ 262.45.
What is 52W high and 52W low share price of Gujarat Themis Biosyn?
The highest and lowest 52W share prices of Gujarat Themis Biosyn are ₹ 390.000 and ₹ 192.350
What is the market cap of Gujarat Themis Biosyn?
The market capitalization of Gujarat Themis Biosyn as of 04 Apr, 2025 is ₹ 2,859.79 Crores
What is the P/E ratio of Gujarat Themis Biosyn?
The current P/E ratio of Gujarat Themis Biosyn as of 04 Apr, 2025 is 44.73
What is the PB ratio of Gujarat Themis Biosyn?
The PB ratio of Gujarat Themis Biosyn as of 04 Apr, 2025 is 9.47
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)